Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by ScienceFirston Jan 15, 2022 10:55pm
753 Views
Post# 34321183

RE:RE:A continuing need for new vaccines

RE:RE:A continuing need for new vaccinesAnother poorly post from Yajne.

Nothing to do with Kool-Aid.

1)  We're lucky to have had access to this new technology (MRNA), when this virus came in, as it had never been tested before.  For example, Moderna had been trying for 12y without success.  Some should also inquire about the initial collaboration between BioNTech and Pfizer in 2018.

2) We're lucky to have had such high level of efficacy.   Despite all this, we had our libertarians that went into all sorts of silly plot theories and refused to get protected and help limit the spread.  This 10% of cons are now clogging 50% of ICU beds, which puts a burden on the healthcare systems and is  preventing some oncology patients to have their surgeries!!!

3) We still don't anything about TLT's vaccine;  for which subset of the population, the efficacy rate, the cost, the infrastructure require to bring it to the mass, etc ...

<< Previous
Bullboard Posts
Next >>